# Human Health Applications of Calcium Montmorillonite Clay: A Systems-Based Review

**Authors:** Mitchell K Ng, David J Jacofsky, Wael K Barsoum, Michael A Mont

PMC · DOI: 10.7759/cureus.95449 · 2025-10-26

## TL;DR

Calcium montmorillonite clay shows promise in various health applications, including gut health, skin care, and toxin removal, with a strong safety profile.

## Contribution

This review systematically compiles evidence on the therapeutic uses of calcium montmorillonite across multiple human body systems.

## Key findings

- Calcium montmorillonite effectively treats gastrointestinal issues like pediatric diarrhea and radiation enteritis.
- The clay shows potential in dermatology for acne, rashes, and wound healing when applied topically.
- It may reduce liver fat and improve glucose metabolism in models of non-alcoholic fatty liver disease and obesity.

## Abstract

Calcium montmorillonite (CMM) clay is a naturally occurring mineral with a longstanding history in medical applications, now receiving increased scientific attention for its broad therapeutic potential. Known for its ability to bind a range of harmful substances, including bacterial toxins, heavy metals, mycotoxins, and inflammatory mediators, it exerts its effects without systemic absorption, acting locally within the gastrointestinal tract or at the skin surface. This narrative review synthesizes current clinical and preclinical evidence on the human health applications of calcium montmorillonite, with focused sections on the gastrointestinal/metabolic, dermatologic, immune, and musculoskeletal systems. The gastrointestinal section covers its documented role in treating pediatric diarrhea, radiation enteritis, and dietary toxin exposure. In dermatology, the clay has been incorporated into topical preparations for acne, rashes, and wound care, supported by both laboratory data and real-world use. Hepatic and metabolic studies suggest that it may reduce liver fat accumulation, improve glucose metabolism, and modulate the gut microbiome, particularly in models of non-alcoholic fatty liver disease and obesity. Additional sections explore its potential relevance in renal toxin clearance, immune regulation, mucosal healing, and surgical recovery. Across these systems, calcium montmorillonite has demonstrated a strong safety profile, with minimal nutrient interaction and no evidence of systemic toxicity when properly sourced and used in appropriate contexts. With growing access to carefully studied, pharmaceutical-grade formulations, CMM may offer safe and consistent benefits across clinical and preventive care settings.

## Linked entities

- **Diseases:** non-alcoholic fatty liver disease (MONDO:0013209), obesity (MONDO:0011122)

## Full-text entities

- **Diseases:** radiation enteritis (MESH:D004751), diarrhea (MESH:D003967), acne (MESH:D000152), obesity (MESH:D009765), toxicity (MESH:D064420), inflammatory (MESH:D007249), rashes (MESH:D005076), non-alcoholic fatty liver disease (MESH:D065626)
- **Chemicals:** heavy metals (MESH:D019216), glucose (MESH:D005947), CMM (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], gut metagenome (species) [taxon 749906]

---
Source: https://tomesphere.com/paper/PMC12646128